Health & Fitness
Mon, March 18, 2013Sun, March 17, 2013Fri, March 15, 2013Thu, March 14, 2013Wed, March 13, 2013Tue, March 12, 2013Mon, March 11, 2013Sun, March 10, 2013Sat, March 9, 2013Fri, March 8, 2013Thu, March 7, 2013Wed, March 6, 2013Tue, March 5, 2013Mon, March 4, 2013Sun, March 3, 2013Sat, March 2, 2013Fri, March 1, 2013Thu, February 28, 2013Wed, February 27, 2013Tue, February 26, 2013Mon, February 25, 2013Sun, February 24, 2013Sat, February 23, 2013Fri, February 22, 2013Lilly Sets Date for 2013 Diabetes Pipeline Update to the Media and Investment Community
Published in Health and Fitness on Tuesday, March 5th 2013 at 5:16 GMT by Market Wire
Lilly Sets Date for 2013 Diabetes Pipeline Update to the Media and Investment... -- INDIANAPOLIS, March 5, 2013 /PRNewswire/ --
INDIANAPOLIS, March 5, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: [ LLY ]) will conduct a conference call for the media and investment community to provide a pipeline update for its diabetes business on Monday, June 24, 2013. The call, which is being held in conjunction with the 73rd American Diabetes Association Scientific Sessions, will include updates on Phase III data for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor, and dulaglutide, an investigational once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist. Empagliflozin is in development in partnership with Boehringer Ingelheim.
The conference call will be held from 7 p.m. to 8:30 p.m. US Central Time (CDT). Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at [ www.lilly.com ]. The webcast of the conference call will be available for replay through July 24, 2013.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at [ www.lilly.com ].
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions—from medicines to support programs and more—to make lives better. For more information, visit [ www.lillydiabetes.com ].
P-LLY
Refer to: | (317) 701-4007 – Kelley Murphy (media) |
(317) 655-6874 – Philip Johnson (investors) |
(Logo: [ http://photos.prnewswire.com/prnh/20031219/LLYLOGO ] )
(Logo: [ http://photos.prnewswire.com/prnh/20111111/DE03493LOGO ] )
SOURCE Eli Lilly and Company
RELATED LINKS
[ http://www.lilly.com ]
